Cargando…
Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors
The human norepinephrine transporter (NET) is an established drug target for a wide range of psychiatric disorders. Conventional methods that are used to functionally characterize NET inhibitors are based on the use of radiolabeled or fluorescent substrates. These methods are highly informative, but...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192900/ https://www.ncbi.nlm.nih.gov/pubmed/34112854 http://dx.doi.org/10.1038/s41598-021-91700-7 |
_version_ | 1783706135738449920 |
---|---|
author | Sijben, Hubert J. van Oostveen, Wieke M. Hartog, Peter B. R. Stucchi, Laura Rossignoli, Andrea Maresca, Giovanna Scarabottolo, Lia IJzerman, Adriaan P. Heitman, Laura H. |
author_facet | Sijben, Hubert J. van Oostveen, Wieke M. Hartog, Peter B. R. Stucchi, Laura Rossignoli, Andrea Maresca, Giovanna Scarabottolo, Lia IJzerman, Adriaan P. Heitman, Laura H. |
author_sort | Sijben, Hubert J. |
collection | PubMed |
description | The human norepinephrine transporter (NET) is an established drug target for a wide range of psychiatric disorders. Conventional methods that are used to functionally characterize NET inhibitors are based on the use of radiolabeled or fluorescent substrates. These methods are highly informative, but pose limitations to either high-throughput screening (HTS) adaptation or physiologically accurate representation of the endogenous uptake events. Recently, we developed a label-free functional assay based on the activation of G protein-coupled receptors by a transported substrate, termed the TRACT assay. In this study, the TRACT assay technology was applied to NET expressed in a doxycycline-inducible HEK 293 JumpIn cell line. Three endogenous substrates of NET—norepinephrine (NE), dopamine (DA) and epinephrine (EP)—were compared in the characterization of the reference NET inhibitor nisoxetine. The resulting assay, using NE as a substrate, was validated in a manual HTS set-up with a Z′ = 0.55. The inhibitory potencies of several reported NET inhibitors from the TRACT assay showed positive correlation with those from an established fluorescent substrate uptake assay. These findings demonstrate the suitability of the TRACT assay for HTS characterization and screening of NET inhibitors and provide a basis for investigation of other solute carrier transporters with label-free biosensors. |
format | Online Article Text |
id | pubmed-8192900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-81929002021-06-14 Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors Sijben, Hubert J. van Oostveen, Wieke M. Hartog, Peter B. R. Stucchi, Laura Rossignoli, Andrea Maresca, Giovanna Scarabottolo, Lia IJzerman, Adriaan P. Heitman, Laura H. Sci Rep Article The human norepinephrine transporter (NET) is an established drug target for a wide range of psychiatric disorders. Conventional methods that are used to functionally characterize NET inhibitors are based on the use of radiolabeled or fluorescent substrates. These methods are highly informative, but pose limitations to either high-throughput screening (HTS) adaptation or physiologically accurate representation of the endogenous uptake events. Recently, we developed a label-free functional assay based on the activation of G protein-coupled receptors by a transported substrate, termed the TRACT assay. In this study, the TRACT assay technology was applied to NET expressed in a doxycycline-inducible HEK 293 JumpIn cell line. Three endogenous substrates of NET—norepinephrine (NE), dopamine (DA) and epinephrine (EP)—were compared in the characterization of the reference NET inhibitor nisoxetine. The resulting assay, using NE as a substrate, was validated in a manual HTS set-up with a Z′ = 0.55. The inhibitory potencies of several reported NET inhibitors from the TRACT assay showed positive correlation with those from an established fluorescent substrate uptake assay. These findings demonstrate the suitability of the TRACT assay for HTS characterization and screening of NET inhibitors and provide a basis for investigation of other solute carrier transporters with label-free biosensors. Nature Publishing Group UK 2021-06-10 /pmc/articles/PMC8192900/ /pubmed/34112854 http://dx.doi.org/10.1038/s41598-021-91700-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Sijben, Hubert J. van Oostveen, Wieke M. Hartog, Peter B. R. Stucchi, Laura Rossignoli, Andrea Maresca, Giovanna Scarabottolo, Lia IJzerman, Adriaan P. Heitman, Laura H. Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors |
title | Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors |
title_full | Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors |
title_fullStr | Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors |
title_full_unstemmed | Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors |
title_short | Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors |
title_sort | label-free high-throughput screening assay for the identification of norepinephrine transporter (net/slc6a2) inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192900/ https://www.ncbi.nlm.nih.gov/pubmed/34112854 http://dx.doi.org/10.1038/s41598-021-91700-7 |
work_keys_str_mv | AT sijbenhubertj labelfreehighthroughputscreeningassayfortheidentificationofnorepinephrinetransporternetslc6a2inhibitors AT vanoostveenwiekem labelfreehighthroughputscreeningassayfortheidentificationofnorepinephrinetransporternetslc6a2inhibitors AT hartogpeterbr labelfreehighthroughputscreeningassayfortheidentificationofnorepinephrinetransporternetslc6a2inhibitors AT stucchilaura labelfreehighthroughputscreeningassayfortheidentificationofnorepinephrinetransporternetslc6a2inhibitors AT rossignoliandrea labelfreehighthroughputscreeningassayfortheidentificationofnorepinephrinetransporternetslc6a2inhibitors AT marescagiovanna labelfreehighthroughputscreeningassayfortheidentificationofnorepinephrinetransporternetslc6a2inhibitors AT scarabottololia labelfreehighthroughputscreeningassayfortheidentificationofnorepinephrinetransporternetslc6a2inhibitors AT ijzermanadriaanp labelfreehighthroughputscreeningassayfortheidentificationofnorepinephrinetransporternetslc6a2inhibitors AT heitmanlaurah labelfreehighthroughputscreeningassayfortheidentificationofnorepinephrinetransporternetslc6a2inhibitors |